115 related articles for article (PubMed ID: 35801270)
1. Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer.
Haddad G; Hueniken K; Xu MC; Bratman S; de Almeida J; Goldstein D; Huang SH; Hansen A; Hope A; Spreafico A; Xu W; Liu G
Head Neck; 2022 Oct; 44(10):2181-2196. PubMed ID: 35801270
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129.
Xiao C; Hanlon A; Zhang Q; Movsas B; Ang K; Rosenthal DI; Nguyen-Tan PF; Kim H; Le Q; Bruner DW
Cancer; 2014 Mar; 120(6):848-54. PubMed ID: 24338990
[TBL] [Abstract][Full Text] [Related]
3. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
Ren J; Pang W; Hueniken K; Haddad G; Hope A; Huang SH; Spreafico A; Hansen AR; Perez-Ordonez B; Goldstein DP; Bratman SV; Zhang W; Zhao Y; Xu W; de Almeida JR; Liu G
Cancer; 2022 Feb; 128(3):497-508. PubMed ID: 34597435
[TBL] [Abstract][Full Text] [Related]
5. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
6. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
[TBL] [Abstract][Full Text] [Related]
7. Insurance Status as a Predictor of Treatment in Human Papillomavirus Positive Oropharyngeal Cancer.
Berger MH; Yasaka TM; Haidar YM; Kuan EC; Tjoa T
Laryngoscope; 2021 Apr; 131(4):776-781. PubMed ID: 32790156
[TBL] [Abstract][Full Text] [Related]
8. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Goepfert RP; Duvall A; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Shete S
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):615-623. PubMed ID: 33956062
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers.
Lafata KJ; Chang Y; Wang C; Mowery YM; Vergalasova I; Niedzwiecki D; Yoo DS; Liu JG; Brizel DM; Yin FF
Med Phys; 2021 Jul; 48(7):3767-3777. PubMed ID: 33959972
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
11. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
12. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
[TBL] [Abstract][Full Text] [Related]
13. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
[TBL] [Abstract][Full Text] [Related]
14. Identification, Associated Factors, and Prognosis of Symptom Clusters in Taiwanese Patients With Heart Failure.
Huang TY; Moser DK; Hwang SL
J Nurs Res; 2018 Feb; 26(1):60-67. PubMed ID: 28221187
[TBL] [Abstract][Full Text] [Related]
15. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.
; Eraj SA; Jomaa MK; Rock CD; Mohamed ASR; Smith BD; Smith JB; Browne T; Cooksey LC; Williams B; Temple B; Preston KE; Aymard JM; Gross ND; Weber RS; Hessel AC; Ferrarotto R; Phan J; Sturgis EM; Hanna EY; Frank SJ; Morrison WH; Goepfert RP; Lai SY; Rosenthal DI; Mendoza TR; Cleeland CS; Hutcheson KA; Fuller CD; Garden AS; Gunn GB
Radiat Oncol; 2017 Sep; 12(1):150. PubMed ID: 28888224
[TBL] [Abstract][Full Text] [Related]
16. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
Vawda N; Banerjee RN; Debenham BJ
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1125-1131. PubMed ID: 30513378
[TBL] [Abstract][Full Text] [Related]
17. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status.
Lop J; García J; López M; Taberna M; Mena M; Alemany L; Quer M; León X
Head Neck; 2019 May; 41(5):1328-1334. PubMed ID: 30549389
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and survival of patients with oropharyngeal cancer.
Ang KK; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman CC; Redmond KP; Gillison ML
N Engl J Med; 2010 Jul; 363(1):24-35. PubMed ID: 20530316
[TBL] [Abstract][Full Text] [Related]
19. The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer.
Liu HY; Daniels CP; Trada Y; Bernard A; You KH; Brown E; Foote M; McGrath M; Ladwa R; Panizza BJ; Porceddu SV
Head Neck; 2021 May; 43(5):1440-1450. PubMed ID: 33427358
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
